These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Regulatory challenges of convalescent plasma collection during the evolving stages of COVID-19 pandemic in the United States. Hassan S; West KA; Conry-Cantilena K; De Giorgi V Transfusion; 2022 Feb; 62(2):483-492. PubMed ID: 34778974 [No Abstract] [Full Text] [Related]
3. SARS-CoV-2 neutralizing capacity among blood donors without prior COVID-19 symptomatic history vs. blood donors with prior COVID-19 symptomatic history: A comparative study. Ravula U; Chunchu SR; Mooli S; Naik R; Sarangapati PRR Transfus Clin Biol; 2022 May; 29(2):107-111. PubMed ID: 35167958 [TBL] [Abstract][Full Text] [Related]
4. Decrease in serum antibodies to SARS-CoV-2 in convalescent plasma donors over time. Prus K; Alquist CR; Cancelas JA; Oh D Transfusion; 2021 Feb; 61(2):651-654. PubMed ID: 33616966 [No Abstract] [Full Text] [Related]
5. Seroprevalence of SARS-CoV-2 among potential convalescent plasma donors and analysis of their deferral pattern: Experience from tertiary care hospital in western India. Jain R; Mallya MV; Amoncar S; Palyekar S; Adsul HP; Kumar R; Chawla S Transfus Clin Biol; 2022 Feb; 29(1):60-64. PubMed ID: 34302953 [TBL] [Abstract][Full Text] [Related]
6. The lack of anti-PF4 antibodies in convalescent plasma from COVID-19 infected blood donor. Piccin A; Mullin B; Brown A; Benson G Transfus Med; 2023 Jun; 33(3):272-273. PubMed ID: 36994550 [No Abstract] [Full Text] [Related]
7. Correlation between ABO blood group and neutralizing anti-SARS-CoV-2 antibody titers in convalescent plasma donations. Franchini M; Mengoli C; Ballotari A; Glingani C Transfus Clin Biol; 2022 May; 29(2):186-187. PubMed ID: 34690072 [No Abstract] [Full Text] [Related]
8. Convalescent blood plasma (CBP) donated by recovered COVID-19 patients - A comment. Lung T; Sakem B; Risch M; Nydegger U Transfus Apher Sci; 2021 Jun; 60(3):103108. PubMed ID: 33678561 [No Abstract] [Full Text] [Related]
9. ABO blood group does not influence the level of anti-SARS-CoV-2 antibodies in convalescent plasma donors. Žiberna K; Jež M; Jazbec K; Mali P; Potokar UR; Rožman P Transfusion; 2022 Mar; 62(3):556-562. PubMed ID: 35041206 [TBL] [Abstract][Full Text] [Related]
10. Demographic and Clinical Factors Associated with Reactivity of Anti-SARS-CoV-2 Antibodies in Serbian Convalescent Plasma Donors. Grujić J; Bujandrić N; Budakov-Obradović Z; Dolinaj V; Bogdan D; Savić N; Cabezas-Cruz A; Mijatović D; Simin V; Anđelić N; Banović P Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010301 [TBL] [Abstract][Full Text] [Related]
11. A trend of dropping anti-SARS-CoV-2 plaque reduction neutralization test titers over time in Canadian convalescent plasma donors. Drews SJ; Devine DV; McManus J; Mendoza E; Manguiat K; Wood H; Girardin R; Dupuis A; McDonough K; Drebot M Transfusion; 2021 May; 61(5):1440-1446. PubMed ID: 33734448 [TBL] [Abstract][Full Text] [Related]
19. COVID-19 Convalescent Plasma: from donation to treatment - A Systematic Review & Single Center Experience. Fabricius MM; Dandachi D Mo Med; 2021; 118(1):74-80. PubMed ID: 33551490 [TBL] [Abstract][Full Text] [Related]
20. Analysis of 52 240 source plasma donors of convalescent COVID-19 plasma: Sex, ethnicity, and age association with initial antibody levels and rate of dissipation. Schmidt AE; Vogel P; Chastain CA; Barnes T; Roth NJ; Simon TL J Clin Apher; 2022 Oct; 37(5):449-459. PubMed ID: 35815776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]